Protara Therapeutics
TARA
30 hedge funds and large institutions have $22.4M invested in Protara Therapeutics in 2018 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 5 closing their positions.
64% more capital invested
Capital invested by funds: $13.6M → $22.4M (+$8.71M)
0% more funds holding
Funds holding: 30 → 30 (0)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
0% more ownership
Funds ownership: 1.26% → 1.26% (+0%)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
67% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$78.7K |
| 2 |
BFM
Boothbay Fund Management
New York
|
+$68.3K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$41.1K |
| 4 |
DS
DRW Securities
Chicago,
Illinois
|
+$34.1K |
| 5 |
VF
Virtu Financial
New York
|
+$33.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WS
Wedbush Securities
Los Angeles,
California
|
-$53K |
| 2 |
KCM
Kornitzer Capital Management
Shawnee Mission,
Kansas
|
-$21K |
| 3 |
ACM
Asymmetry Capital Management
San Francisco,
California
|
-$18K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$16.9K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$13.2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Royal Bank of Canada
Toronto,
Ontario, Canada
| $10K | – | – | – |
|
27
BlackRock
New York
| $9K | -$2.73K | -30 | -25% |
|
|
SPIA
28
Steward Partners Investment Advisory
New York
| $5K | +$4.55K | +50 | New |
|
29
Morgan Stanley
New York
| $1K | +$910 | +10 | New |
|
|
WS
30
Wedbush Securities
Los Angeles,
California
| – | -$53K | -698 | Closed |
|
|
KCM
31
Kornitzer Capital Management
Shawnee Mission,
Kansas
| – | -$21K | -283 | Closed |
|
|
ACM
32
Asymmetry Capital Management
San Francisco,
California
| – | -$18K | -235 | Closed |
|
|
33
UBS Group
Zurich,
Switzerland
| – | -$13.2K | -145 | -98% |
|
|
PCM
34
Prelude Capital Management
New York
| – | -$9K | -124 | Closed |
|
35
Macquarie Group
Sydney, NSW 2000,
Australia
| – | -$6K | -85 | Closed |
|
TARA Hedge Fund Activity: Q1 2018 in Review
30 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Protara Therapeutics (TARA) for Q1 2018, worth a combined $22.4M — up 64% from $13.6M a quarter earlier.
Fund positioning in TARA was balanced in Q1 2018: 5 funds opened new positions, 5 closed out, 2 added to existing stakes and 6 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $78.7K. The largest seller was Wedbush Securities, exiting entirely with an estimated $53K sold.
- 30 institutional investors held Protara Therapeutics (TARA) as of Q1 2018, unchanged from Q4 2017.
- Funds reported $22.4M of Protara Therapeutics stock for Q1 2018, up 64% quarter-over-quarter.
- 5 funds opened new Protara Therapeutics positions in Q1 2018 and 5 closed out, a net change of 0 holders.
- The largest Protara Therapeutics buyer in Q1 2018 was Renaissance Technologies, an estimated $78.7K added.
- The largest Protara Therapeutics seller in Q1 2018 was Wedbush Securities, an estimated $53K sold.
Based on aggregated 13F filings for Q1 2018.